based purely on surgical specimens, and ours on autopsy material, the differences in results are obvious; for example, in contrast to his 15.9 percent figure for synchronous multiple primary malignant tumors of the large bowel, three of our 174 (1.72 percent) large-bowel cancers were synchronous. Pagana et al., 2 on the other hand, found, among 157 patients with a primary colorectal cancer, 12 patients (7.2 percent) who had a synchronously occurring second large-bowel cancer, on total colonoscopy. Furthermore, we did not notice concurrent occurrence of polyps and synchronous large-bowel tumors; notwithstanding, we also believe that the majority of large-bowel carcinomas are preceded by villous or adenomatous polyps.
The Authors Reply
To the Editor:--We are grateful for the interest Dr. Fogler has shown in our recent article. ~ His comments, however, deal with a very small aspect of our paper, namely, synchronous malignant tumors of the large bowel. Since Dr. Fogler's data are based purely on surgical specimens, and ours on autopsy material, the differences in results are obvious; for example, in contrast to his 15.9 percent figure for synchronous multiple primary malignant tumors of the large bowel, three of our 174 (1.72 percent) large-bowel cancers were synchronous. Pagana et al., 2 on the other hand, found, among 157 patients with a primary colorectal cancer, 12 patients (7.2 percent) who had a synchronously occurring second large-bowel cancer, on total colonoscopy. Furthermore, we did not notice concurrent occurrence of polyps and synchronous large-bowel tumors; notwithstanding, we also believe that the majority of large-bowel carcinomas are preceded by villous or adenomatous polyps.
In a previous contribution, 3 alluded to in his letter, Dr. Fogler addressed the fascinating issue of the simultaneous occurrence of carcinoid and noncarcinoid malignant tumors. In our study, although carcinoids accounted for 0.6 percent of all malignant tumors, five of 12 patients (41.7 percent) with carcinoids had a second cancer, one each being carcinoma of the rectum, lung, breast, and kidney, and one malignant melanoma (unpublished data).
Indeed, we are pleased to learn that Dr. Fogler supports our contention that there should be a thorough search for additional tumors at the time of detection of the initial tumor, and that aggressive operative therapy is warranted.
Oslo, Norwa~
To the Editor:--Thank you for the opportunity of replying to Dr. Fogler's letter.
Large-bowel neoplasia is a muhifocal disease. However, the incidence reported by Dr. Fogler, of synchronous tumors (benign and malignant), in patients with largebowel cancer, greatly exceeds that found by us and others. ~,z In part, this discrepancy is explained by the high proportion of patients in Dr. Fogler's series who underwent colonoscopy, whereas the majority of our patients were investigated by barium-enema.
In our series, 2.5 percent of all patients had synchronous carcinomas, of whom three fourths had associated multiple adenomas. Metachronous neoplasia developed in 2.7 percent of all patients, and metachronous carcinoma in 1.9 percent. These figures are in agreement with results reported from St. Mark's Hospital, LondonP From our review, it was apparent that the likelihood of developing metachronous neoplasia is increased greatly in patients with synchronous lesions at the time of diagnosis.
To establish the presence or absence of synchronous neoplasia, we support Dr. Fogler's view that all patients diagnosed with colorectal carcinoma should, if feasible, undergo preoperative screening of the entire large bowel, preferably by colonoscopy. Furthermore, in those patients with synchronous lesions, postoperative review should include regular screening of the remaining large bowel. In view of the low incidence of metachronous neoplasia in our series, we would not support Dr. Fogler's belief that near-subtotal colectomy is the operation of choice for cancer, except in patients with synchronous carcinomas or adenomas.
